Search

Author/Creator Eder, Joseph Paul

1. Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations). (2021)

Authors:
Mahdi, Haider; Hafez, Navid; Doroshow, Deborah; Sohal, Davendra; Keedy, Vickie; Do, Khanh T.; LoRusso, Patricia; Jürgensmeier, Juliane; Avedissian, Manuel; Sklar, Jeffrey; Glover, Colin; Felicetti, Brunella; Dean, Emma; Mortimer, Peter; Shapiro, Geoffrey I.; Eder, Joseph Paul
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Financial toxicity in patients with advanced solid malignancies participating in early-phase clinical trials. Issue 28 (1st October 2022)

Authors:
Blanter, Julia; Werner, Michael; Kier, Melanie Wain; Hapanowicz, Olivia; Itani, Muhieddine; Ahmad, Maham; DeMerchant, Mandy; Eder, Joseph Paul; Galsky, Matt D.; Hammad, Ashley; King, Paula; Lachowicz, Michael; Lucas, Natalie; Marron, Thomas Urban; Shelton, Gary; Wu, Kathy; Xu, Suzanne; LoRusso, P...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 28(2022)Supplement
Page Start:
267
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial. Issue 7 (July 2016)

Authors:
Antonia, Scott J; López-Martin, José A; Bendell, Johanna; Ott, Patrick A; Taylor, Matthew; Eder, Joseph Paul; Jäger, Dirk; Pietanza, M Catherine; Le, Dung T; de Braud, Filippo; Morse, Michael A; Ascierto, Paolo A; Horn, Leora; Amin, Asim; Pillai, Rathi N; Evans, Jeffry; Chau, Ian; Bono, Petri; At...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 7(2016:Jul.)
Page Start:
883
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Issue 6 (June 2016)

Authors:
Muro, Kei; Chung, Hyun Cheol; Shankaran, Veena; Geva, Ravit; Catenacci, Daniel; Gupta, Shilpa; Eder, Joseph Paul; Golan, Talia; Le, Dung T; Burtness, Barbara; McRee, Autumn J; Lin, Chia-Chi; Pathiraja, Kumudu; Lunceford, Jared; Emancipator, Kenneth; Juco, Jonathan; Koshiji, Minori; Bang, Yung-Jue
Journal:
Lancet oncology
Issue:
Volume 17:Issue 6(2016:Jun.)
Page Start:
717
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study. Issue 4 (April 2019)

Authors:
Leighl, Natasha B; Hellmann, Matthew D; Hui, Rina; Carcereny, Enric; Felip, Enriqueta; Ahn, Myung-Ju; Eder, Joseph Paul; Balmanoukian, Ani S; Aggarwal, Charu; Horn, Leora; Patnaik, Amita; Gubens, Matthew; Ramalingam, Suresh S; Lubiniecki, Gregory M; Zhang, Jin; Piperdi, Bilal; Garon, Edward B
Journal:
Lancet
Issue:
Volume 7:Issue 4(2019)
Page Start:
347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032. (4th November 2015)

Authors:
Taylor, Matthew; Antonia, Scott; Bendell, Johanna; Calvo, Emiliano; Jäger, Dirk; de Braud, Filippo; Ott, Patrick A; Pietanza, M Catherine; Horn, Leora; Le, Dung T; Morse, Michael A; López-Martin, José A; Ascierto, Paolo A; Christensen, Olaf; Simon, Jason S; Lin, Chen-Sheng; Eder, Joseph Paul
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Issue 7 (July 2016)

Authors:
Seiwert, Tanguy Y; Burtness, Barbara; Mehra, Ranee; Weiss, Jared; Berger, Raanan; Eder, Joseph Paul; Heath, Karl; McClanahan, Terrill; Lunceford, Jared; Gause, Christine; Cheng, Jonathan D; Chow, Laura Q
Journal:
Lancet oncology
Issue:
Volume 17:Issue 7(2016:Jul.)
Page Start:
956
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗